Delivery Order SPE2DB22D3010-SPE2DB24FP2MR
- Not listed
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $10,662.57 delivery order contract is for the supply of the pharmaceutical product Tagrisso 80 mg tablet 30s. The contract is a firm fixed-price, non-set-aside award with a completion date of June 11, 2025. Amerisourcebergen Drug Corp holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $10,662.57 delivery order contract is for the medication TAGRISSO 80 MG TABLET 30S. The contract is a firm fixed-price, non-set-aside award with a completion date of July 3, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of TAGRISSO 80 MG TABLET 30S. The contract has a ceiling value of $10,662.57 and runs through April 9, 2025. It was awarded by the Defense Logistics Agency (DLA), a defense agency, and is a Firm Fixed Price Delivery Order contract type. There is no set-aside designation for this award. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,565,917,052 tablets of the prescription drug TAGRISSO 40 MG. The contract, valued at $21,016.64, was awarded by the Defense Logistics Agency (DLA) on September 24, 2024, with a completion date of October 16, 2024. This is a Firm Fixed Price Delivery Order contract with no set-aside designation. Amerisourcebergen is a major pharmaceutical distributor and supplier of medical products...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of the pharmaceutical product TAGRISSO 80 MG TABLET 30S to the Medical Supply Chain, a part of the Defense agency. The $21,077.60 firm fixed-price delivery order contract has a completion date of June 17, 2024. Amerisourcebergen, a major pharmaceutical distributor, is providing these prescription drugs to support the Department of Defense's medical treatment programs and facilities worldwide....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distributor. The $10,508.31 firm fixed price delivery order is for the supply of the pharmaceutical product Tagrisso 40 mg Tablet 30s. The award has an ultimate completion date of April 3, 2024 and does not utilize any set-aside designations. Amerisourcebergen Drug Corp serves as a prime contractor for DLA,...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of the pharmaceutical product Tagrisso 40 mg tablets. The contract is a firm fixed-price award with a ceiling value of $10,508.31 and a period of performance through November 1, 2024. As one of the largest pharmaceutical distributors in the U.S., AmerisourceBergen has been awarded numerous federal contracts to provide a wide range of prescription medications, medical supplies, and...
- This federal contract award, valued at $21,282.14, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the medication Tagrisso 40 mg tablet in 30-count packages, with a completion date of May 5, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which serves as a...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, valued at $10,093.47, is for the delivery of Tagrisso 80 mg Tablets in a quantity of 30. The contract is a Firm Fixed Price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $21,077.60 firm fixed price contract is for the supply of Tagrisso 80 mg tablets, a specialty oncology medication. This delivery order falls under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, which enables the government to efficiently procure a wide range of...
- SPE2DB22D3010Indefinite Delivery Contract
- SPE2DB22D3010-SPE2DB24FP2MRDelivery Order
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, valued at $21,016.64, is for the delivery of Tagrisso 40 mg tablets. The contract, awarded by the Defense Logistics Agency (DLA), is a delivery order under an Indefinite Delivery Contract (IDC) with a ceiling value of up to $999,999,999.00. This single-award IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract does not have a set-aside designation. Amerisourcebergen, a major pharmaceutical distribution company, leverages its extensive supply chain network to efficiently fulfill government contracts for critical medical commodities, including specialty, brand name, generic, and over-the-counter medications, as well as supplies such as syringes and test kits.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $21.0k | 5/29/24 |